Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-09-014239
Filing Date
2009-07-31
Accepted
2009-07-31 17:04:12
Documents
1
Period of Report
2009-07-22

Document Format Files

Seq Description Document Type Size
1 p1017422_ex.html 3  
1 p1017422_ex.xml 3 5480
  Complete submission text file 0000919574-09-014239.txt   7930
Mailing Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033
Business Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033 (323) 224-3900
RESPONSE GENETICS INC (Issuer) CIK: 0001124608 (see all company filings)

EIN.: 000000000
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 15 DAVIES STREET LONDON X0 W1K 3AG
Business Address 15 DAVIES STREET LONDON X0 W1K 3AG 44-20-7290-5500
LANSDOWNE PARTNERS LIMITED PARTNERSHIP (Reporting) CIK: 0001315309 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33509 | Film No.: 09978026

Mailing Address C/O FORTIS PRIME FUND SOLUTIONS FORTIS HOUSE, PARK LANE, SPENCER DOCK DUBLIN L2 1
Business Address C/O FORTIS PRIME FUND SOLUTIONS FORTIS HOUSE, PARK LANE, SPENCER DOCK DUBLIN L2 1 353 1 607 1800
LANSDOWNE UK STRATEGIC INVESTMENT MASTER FUND LTD (Reporting) CIK: 0001469444 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33509 | Film No.: 09978025